产品描述信息
HM-200??Enterococcus faecalis, HH22 (Bacteria)|Enterococcus faecalis| HH22 |-80°C or colder|BE MurrayAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH as part of the Human Microbiome Project: Enterococcus faecalis, Strain HH22, HM-200."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. Enterococcus faecalis (
E. faecalis), strain HH22 was isolated in July 1981 from a clinical
specimen submitted to the microbiology laboratory of Hermann Hospital in
Houston, Texas, USA.
E. faecalis, strain HH22
(
HMP ID 0346) is reported
to be the first known beta-lactamase producing isolate and resistant to
gentamicin. This
strain is a reference genome for
The
Human Microbiome Project (HMP). HMP
is an initiative to identify and characterize human microbial flora.
E. faecalis, strain HH22 was sequenced at the Human Genome
Sequencing Center at
Baylor
College of Medicine (GenBank:
ACIX00000000). Each vial of lot 60190300 contains
approximately 0.5 mL of bacterial culture in Brain Heart Infusion broth
supplemented with 10% glycerol. Each vial of lot
64498968 contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10%
glycerol.